SLC12A5 and epilepsy: The association between loss-of-function KCC2 mutations and epilepsy also suggests that augmenting KCC2 activity to enhance Cl− extrusion may confer the opposite effect of rendering neuronal cells more resistant to seizures, representing a potentially powerful therapeutic avenue for idiopathic epilepsy.